These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178 [TBL] [Abstract][Full Text] [Related]
5. Characterizing the multiple roles of FGF-2 in SOD1 Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540 [TBL] [Abstract][Full Text] [Related]
6. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Turner BJ; Ackerley S; Davies KE; Talbot K Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901 [TBL] [Abstract][Full Text] [Related]
7. Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis. O'Reilly SA; Roedica J; Nagy D; Hallewell RA; Alderson K; Marklund SL; Kuby J; Kushner PD Exp Neurol; 1995 Feb; 131(2):203-10. PubMed ID: 7895821 [TBL] [Abstract][Full Text] [Related]
8. [ALS and microglia--a player for non-cell-autonomous neuron death]. Yamanaka K; Yamashita H Brain Nerve; 2007 Oct; 59(10):1163-70. PubMed ID: 17969357 [TBL] [Abstract][Full Text] [Related]
9. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799 [TBL] [Abstract][Full Text] [Related]
10. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487 [TBL] [Abstract][Full Text] [Related]
11. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
12. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS). Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020 [TBL] [Abstract][Full Text] [Related]
14. Patient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology. García-Escudero V; Rosales M; Muñoz JL; Scola E; Medina J; Khalique H; Garaulet G; Rodriguez A; Lim F J Cell Mol Med; 2015 Jun; 19(6):1284-95. PubMed ID: 25807871 [TBL] [Abstract][Full Text] [Related]
15. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Hall ED; Oostveen JA; Gurney ME Glia; 1998 Jul; 23(3):249-56. PubMed ID: 9633809 [TBL] [Abstract][Full Text] [Related]
16. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702 [TBL] [Abstract][Full Text] [Related]
17. Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis. Trias E; Ibarburu S; Barreto-Núñez R; Barbeito L Neurosci Lett; 2017 Jan; 636():27-31. PubMed ID: 27473942 [TBL] [Abstract][Full Text] [Related]
19. Imaging of glial cell morphology, SOD1 distribution and elemental composition in the brainstem and hippocampus of the ALS hSOD1 Stamenković S; Dučić T; Stamenković V; Kranz A; Andjus PR Neuroscience; 2017 Aug; 357():37-55. PubMed ID: 28576725 [TBL] [Abstract][Full Text] [Related]
20. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]